EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques

Agata Czarnywojtek, Magdalena Borowska, Kamil Dyrka, Stefaan Van Gool, Nadia Sawicka-Gutaj, Jakub Moskal, Jeremi Kościński, Patryk Graczyk, Tomasz Hałas, Agnieszka Marta Lewandowska, Rafał Czepczyński, Marek Ruchała

Pharmacology · 2023 · 108 (5) · 423-431

DOI: 10.1159/000531319 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology, online erschienen am 17.07.2023. Verfasst von Agata Czarnywojtek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Oncolytic Virotherapy, Brain Neoplasms. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Glioblastoma multiforme (GBM) is a WHO grade 4 glioma and the most common malignant primary brain tumour. Recently, there has been outstanding progress in the treatment of GBM. In addition to the newest form of GBM removal using fluorescence, three-dimensional (3D) imaging, tomoradiotherapy, moderate electro-hyperthermia, and adjuvant temozolomide (post-operative chemotherapy), new developments have been made in the fields of immunology, molecular biology, and virotherapy. An unusual and modern treatment has been created, especially for stage 4 GBM, using the latest therapeutic techniques, including immunotherapy and virotherapy. Modern oncological medicine is producing extraordinary and progressive therapeutic methods. Oncological therapy includes individual analysis of the properties of a tumour and targeted therapy using small-molecule inhibitors. Individualised medicine covers the entire patient (tumour and host) in the context of immunotherapy. An example is individualised multimodal immunotherapy (IMI), which relies on individual immunological tumour-host interactions. In addition, IMI is based on the concept of oncolytic virus-induced immunogenic tumour cell death. Summary: In this review, we outline current knowledge of the various available treatment options used in the therapy of GBM including both traditional therapeutic strategy and modern therapies, such as tomotherapy, electro-hyperthermia, and oncolytic virotherapy, which are promising treatment strategies with the potential to improve prognosis in patients with GBM. Key Messages: This newest therapy, immunotherapy combined with virotherapy (oncolytic viruses and cancer vaccines), is displaying encouraging signs for combating GBM. Additionally, the latest 3D imaging is compared to conventional two-dimensional imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaGliomaOncolytic VirotherapyBrain NeoplasmsHumansTemozolomide

Stichwörter der Autor:innen

Cancer vaccinesCell-free DNAChemotherapyFluorescence diagnosticsGene mutationGlioblastoma multiformeHSV-G47∆ImmunotherapyLarotrectinibNon-coding RNAsOncolytic virusTargeted therapyTemozolomideThree-dimensional imagingTyrosine kinase inhibitors

Substanzen

Temozolomide

Autor:innen und Institutionen

  • Chair and Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Pediatric Endocrinology and Rheumatology, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, Poland.
  • Immune-Oncological Centre Cologne (IOZK), Cologne, Germany.
  • Department of Neurosurgery, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Oncology, Greater Poland Cancer Centre, Poznan, Poland.

Zitieren

APA

Czarnywojtek, A., Borowska, M., Dyrka, K., Van Gool, S., Sawicka-Gutaj, N., Moskal, J., Kościński, J., Graczyk, P., Hałas, T., Lewandowska, A. M., Czepczyński, R., & Ruchała, M. (2023). Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques. Pharmacology, 108(5), 423-431. https://doi.org/10.1159/000531319

Vancouver

Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J, et al. Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques. Pharmacology. 2023;108(5):423-431. doi:10.1159/000531319

BibTeX
@article{Czarnywojtek2023,
  author = {Czarnywojtek, Agata and Borowska, Magdalena and Dyrka, Kamil and Van Gool, Stefaan and Sawicka-Gutaj, Nadia and Moskal, Jakub and Kościński, Jeremi and Graczyk, Patryk and Hałas, Tomasz and Lewandowska, Agnieszka Marta and Czepczyński, Rafał and Ruchała, Marek},
  title = {Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques},
  journal = {Pharmacology},
  year = {2023},
  volume = {108},
  number = {5},
  pages = {423--431},
  doi = {10.1159/000531319}
}
Kostenlos starten →